サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：分子細胞遺伝の世界市場2023-2030
市場調査レポート
商品コード
1296892

分子細胞遺伝の世界市場2023-2030

Global Molecular Cytogenetics Market 2023-2030
出版日: | 発行: Orion Market Research | ページ情報: 英文 155 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
分子細胞遺伝の世界市場2023-2030
出版日: 2023年05月26日
発行: Orion Market Research
ページ情報: 英文 155 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の分子細胞遺伝市場は、予測期間中にCAGR8.5％で成長すると推定されます。市場成長の主な要因としては、がんの蔓延と遺伝子検査ツールに対する需要の増加が挙げられます。世界保健機関（WHO）の発表によると、2018年の世界のがん負担は、新規患者数1810万人、死亡者数960万人に上るとまする。

地域別展望

北米地域が世界の分子細胞遺伝学市場で大きなシェアを占めると予測される

このうち北米地域は、がんの有病率の高さ、ゲノム研究への資金提供の増加、ライフサイエンス研究における大きなシェアを占めていることから、大きな市場シェアを占めると予想されています。さらに、Abbott Laboratories, Inc.、Thermo Fisher Scientific Inc.、Illumina, Inc.などの大手企業が存在することも、同地域における市場成長の潜在的機会を提供しています。これらの企業は先進的な分子細胞遺伝学ツールの導入に注力しており、市場シェアを拡大する可能性が高いです。

目次

第1章 レポート概要

  • 業界の現状分析と成長ポテンシャルの展望
  • 調査方法とツール
  • 市場内訳
    • セグメント別
    • 地域別

第2章 市場概要と洞察

  • 調査範囲
  • アナリストの洞察と現在の市場動向
    • 主な調査結果
    • 推奨事項
    • 結論

第3章 競合情勢

  • 主要企業分析
  • Abbott Laboratories, Inc.
    • 概要
    • 財務分析
    • SWOT分析
    • 最近の動向
  • Bio-Rad Laboratories, Inc.
    • 会社概要
    • 財務分析
    • SWOT分析
    • 最近の動向
  • Illumina, Inc.
    • 概要
    • 財務分析
    • SWOT分析
    • 最近の動向
  • F. Hoffmann La-Roche AG
    • 概要
    • 財務分析
    • SWOT分析
    • 最近の動向
  • Thermo Fisher Scientific, Inc.
    • 概要
    • 財務分析
    • SWOT分析
  • 主要戦略分析

第4章 市場セグメンテーション

  • 分子細胞遺伝学の世界市場：製品別
    • 消耗品
    • ソフトウェアとサービス
    • 機器
  • 分子細胞遺伝学の世界市場：用途別
    • がん
    • 遺伝子疾患
    • 個別化医療
  • 分子細胞遺伝学の世界市場：技術別
    • 蛍光in situハイブリダイゼーション（FISH）
    • 比較ゲノムハイブリダイゼーション（CGH）
    • その他

第5章 地域分析

  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • イタリア
    • スペイン
    • フランス
    • その他欧州
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋地域
  • 世界のその他の地域

第6章 企業プロファイル

  • Abbott Laboratories, Inc.
  • ADS Biotec Inc.
  • Agilent Technologies, Inc.
  • Applied Spectral Imaging
  • BioDot Inc.
  • Biological Industries Israel Beit Haemek Ltd.
  • Bio-Rad Laboratories, Inc.
  • Danaher Corp.
  • Euroclone S.p.A.
  • F. Hoffmann La-Roche AG
  • FUJIFILM Irvine Scientific
  • Illumina, Inc.
  • Laboratory Imaging s.r.o.
  • Leica Biosystems
  • MetaSystems Hard & Software GmbH
  • Nikon Corp.
  • Oxford Gene Technology Ltd.
  • PAN-Biotech GmbH
  • Perkinelmer, Inc.
  • Tecan Group Ltd.
  • Thermo Fisher Scientific Inc.
図表

LIST OF TABLES

  • 1. GLOBAL MOLECULAR CYTOGENETICS MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
  • 2. GLOBAL MOLECULAR CYTOGENETICS CONSUMABLES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 3. GLOBAL MOLECULAR CYTOGENETICS SOFTWARE AND SERVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 4. GLOBAL MOLECULAR CYTOGENETICS INSTRUMENTS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 5. GLOBAL MOLECULAR CYTOGENETICS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 6. GLOBAL MOLECULAR CYTOGENETICS FOR CANCER MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 7. GLOBAL MOLECULAR CYTOGENETICS FOR GENETIC DISORDERS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 8. GLOBAL MOLECULAR CYTOGENETICS FOR PERSONALIZED MEDICINE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 9. GLOBAL MOLECULAR CYTOGENETICS MARKET RESEARCH AND ANALYSIS BY TECHNIQUE, 2022-2030 ($ MILLION)
  • 10. GLOBAL FISH FOR MOLECULAR CYTOGENETICS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 11. GLOBAL CGH FOR MOLECULAR CYTOGENETICS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 12. GLOBAL OTHER TECHNIQUES FOR MOLECULAR CYTOGENETICS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 13. GLOBAL MOLECULAR CYTOGENETICS MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2022-2030 ($ MILLION)
  • 14. NORTH AMERICAN MOLECULAR CYTOGENETICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 15. NORTH AMERICAN MOLECULAR CYTOGENETICS MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
  • 16. NORTH AMERICAN MOLECULAR CYTOGENETICS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 17. NORTH AMERICAN MOLECULAR CYTOGENETICS MARKET RESEARCH AND ANALYSIS BY TECHNIQUE, 2022-2030 ($ MILLION)
  • 18. EUROPEAN MOLECULAR CYTOGENETICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 19. EUROPEAN MOLECULAR CYTOGENETICS MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
  • 20. EUROPEAN MOLECULAR CYTOGENETICS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 21. EUROPEAN MOLECULAR CYTOGENETICS MARKET RESEARCH AND ANALYSIS BY TECHNIQUE, 2022-2030 ($ MILLION)
  • 22. ASIA-PACIFIC MOLECULAR CYTOGENETICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 23. ASIA-PACIFIC MOLECULAR CYTOGENETICS MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
  • 24. ASIA-PACIFIC MOLECULAR CYTOGENETICS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 25. ASIA-PACIFIC MOLECULAR CYTOGENETICS MARKET RESEARCH AND ANALYSIS BY TECHNIQUE, 2022-2030 ($ MILLION)
  • 26. REST OF THE WORLD MOLECULAR CYTOGENETICS MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
  • 27. REST OF THE WORLD MOLECULAR CYTOGENETICS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 28. REST OF THE WORLD MOLECULAR CYTOGENETICS MARKET RESEARCH AND ANALYSIS BY TECHNIQUE, 2022-2030 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL MOLECULAR CYTOGENETICS MARKET SHARE BY PRODUCT, 2022 VS 2030 (%)
  • 2. GLOBAL MOLECULAR CYTOGENETICS MARKET SHARE BY APPLICATION, 2022 VS 2030 (%)
  • 3. GLOBAL MOLECULAR CYTOGENETICS MARKET SHARE BY TECHNIQUE, 2022 VS 2030 (%)
  • 4. GLOBAL MOLECULAR CYTOGENETICS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 5. GLOBAL MOLECULAR CYTOGENETICS CONSUMABLES MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 6. GLOBAL MOLECULAR CYTOGENETICS SOFTWARE AND SERVICES MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 7. GLOBAL MOLECULAR CYTOGENETICS INSTRUMENTS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 8. GLOBAL MOLECULAR CYTOGENETICS FOR CANCER MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 9. GLOBAL MOLECULAR CYTOGENETICS FOR GENETIC DISORDERS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 10. GLOBAL MOLECULAR CYTOGENETICS FOR PERSONALIZED MEDICINE MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 11. GLOBAL FISH FOR MOLECULAR CYTOGENETICS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 12. GLOBAL CGH FOR MOLECULAR CYTOGENETICS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 13. GLOBAL OTHER TECHNIQUES FOR MOLECULAR CYTOGENETICS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 14. US MOLECULAR CYTOGENETICS MARKET SIZE, 2022-2030 ($ MILLION)
  • 15. CANADA MOLECULAR CYTOGENETICS MARKET SIZE, 2022-2030 ($ MILLION)
  • 16. UK MOLECULAR CYTOGENETICS MARKET SIZE, 2022-2030 ($ MILLION)
  • 17. FRANCE MOLECULAR CYTOGENETICS MARKET SIZE, 2022-2030 ($ MILLION)
  • 18. GERMANY MOLECULAR CYTOGENETICS MARKET SIZE, 2022-2030 ($ MILLION)
  • 19. ITALY MOLECULAR CYTOGENETICS MARKET SIZE, 2022-2030 ($ MILLION)
  • 20. SPAIN MOLECULAR CYTOGENETICS MARKET SIZE, 2022-2030 ($ MILLION)
  • 21. ROE MOLECULAR CYTOGENETICS MARKET SIZE, 2022-2030 ($ MILLION)
  • 22. INDIA MOLECULAR CYTOGENETICS MARKET SIZE, 2022-2030 ($ MILLION)
  • 23. CHINA MOLECULAR CYTOGENETICS MARKET SIZE, 2022-2030 ($ MILLION)
  • 24. JAPAN MOLECULAR CYTOGENETICS MARKET SIZE, 2022-2030 ($ MILLION)
  • 25. REST OF ASIA-PACIFIC MOLECULAR CYTOGENETICS MARKET SIZE, 2022-2030 ($ MILLION)
  • 26. REST OF THE WORLD MOLECULAR CYTOGENETICS MARKET SIZE, 2022-2030 ($ MILLION)
目次
Product Code: OMR2027343

Global molecular cytogenetics market is estimated to grow at a CAGR of 8.5% during the forecast period. The major factors contributing to the growth of the market include a significant prevalence of Cancer and increasing demand for genetic testing tools. As per the World Health Organization (WHO), the global Cancer burden is estimated to have risen to 18.1 million new cases and 9.6 million mortality in 2018. 43.8 million persons were living with Cancer in 2018 and were diagnosed within the last 5 years. This rising prevalence of Cancer is attributed to the demand for molecular cytogenetic tools.

Fluorescence in-situ hybridization (FISH) study is a crucial tool for both diagnostics and clinical research, as well as diagnostics, in Cancer and Leukemia. FISH can be utilized to assess chromosomal abnormalities with fluorescent-labeled DNA probes that target specific DNA sequences. FISH-based tests and comparative genomic hybridization (CGH), and multicolor karyotyping, have been utilized in clinical applications. These tests allow the whole global scanning of genomic imbalances and the resolution of complex karyotypic aberrations. Cross-species array CGH analysis has been used in the identification of Cancer genes.

The clinical effect of FISH is crucial, primarily in the diagnosis, prognosis, and treatment decisions for hematological conditions, which facilitate the area of personalized medicine. Molecular cytogenetics enables to properly differentiate of Cancer-causing and normal cells, which in turn, is leading to its adoption in Cancer diagnostics. Further, the market has significant growth opportunities owing to the advent of next-generation sequencing (NGS) and increasing research on personalized medicines. However, certain factors restricting market growth include the high cost of instruments and unfavorable reimbursement policies for genomic tools.

Segmental Outlook

The global molecular cytogenetics market is segmented based on its product, application, and technique. Based on product, the market is segmented into consumables, software & services, and instruments. Based on application, the market is categorized into cancer, genetic disorders, and personalized medicine. Further, based on technique, the market is segmented into fluorescence in situ hybridization (FISH), comparative genomic hybridization (CGH), and others. Among the product segments, the consumables segment is expected to hold a prominent market share due to the recurring demand for consumables in diagnostic procedures.

Fluorescence in situ hybridization (FISH) is one of the major techniques in molecular cytogenetics testing.

Molecular cytogenetic techniques mainly rely on FISH, which is based on the principle of complementary hybridization of labeled DNA or RNA probes with normal or abnormal nucleic acid sequences on metaphase chromosomes, interphase cells, or tissue sections. FISH takes us to a colorful chromosome world, which involves a fluorescently labeled DNA probe hybridized to a specific genomic segment of interest. FISH can detect small chromosomal rearrangements that cannot be detected by conventional cytogenetic techniques. The use of the FISH technique enhanced the interpretation of the numerical and complex chromosomal rearrangements, bridging the gap between conventional cytogenetics and molecular biology. Therefore, it is being significantly adopted technique in genome research and cancer diagnostics. In genome research, FISH enables researchers to map and visualize the genetic material in an individual's cells, including portions of genes or specific genes. This technique may be applied to understand a range of chromosomal abnormalities and other genetic mutations.

Regional Outlooks

The global molecular cytogenetics market is further segmented based on geography, including North America, Europe, Asia-Pacific, and the Rest of the World. The market can be analyzed for a particular region or country level as per the requirement. The Asia-Pacific region is projected to experience considerable growth in the molecular cytogenetics market due to rising healthcare expenditure and increasing awareness about personalized medicine in the region.

Global Molecular Cytogenetics Market Growth, by Region 2023-2030

Source: OMR Analysis

The North American Region is anticipated to Hold a Significant Share in the Global Molecular Cytogenetics Market

Among these, the North American region is anticipated to hold a significant market share owing to the significant prevalence of Cancer, increasing funding for genome research, and significant share in life science research in the region. In addition, the presence of major players, including Abbott Laboratories, Inc., Thermo Fisher Scientific Inc., and Illumina, Inc. are offering a potential opportunity for market growth in the region. These companies are focusing on introducing advanced molecular cytogenetics tools that will likely increase their market share.

Market Players Outlook

The major players in the global molecular cytogenetics market include Abbott Laboratories, Inc., Thermo Fisher Scientific Inc., Illumina, Inc., Bio-Rad Laboratories Inc., and F. Hoffman La-Roche AG. Product launches and mergers and acquisitions are considered some key strategies adopted by the market players to increase market share and gain a competitive advantage. For instance, in January 2020, Oxford Gene Technology (OGT) introduced an NGS panel for constitutional cytogenetics research. The CytoSure Constitutional NGS Panel enables reliable and accurate detection of copy number variations (CNVs), insertion/deletions (indels), single nucleotide variations (SNVs), and loss of heterozygosity (LOH), such as in mosaic samples. It combines the advantages of NGS and microarrays in one cost-effective assay. This new launch will likely support those laboratories that are focusing on transitioning from arrays to NGS.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
  • 3.2. Abbott Laboratories, Inc.
    • 3.2.1. Overview
    • 3.2.2. Financial Analysis
    • 3.2.3. SWOT Analysis
    • 3.2.4. Recent Developments
  • 3.3. Bio-Rad Laboratories, Inc.
    • 3.3.1. Overview
    • 3.3.2. Financial Analysis
    • 3.3.3. SWOT Analysis
    • 3.3.4. Recent Developments
  • 3.4. Illumina, Inc.
    • 3.4.1. Overview
    • 3.4.2. Financial Analysis
    • 3.4.3. SWOT Analysis
    • 3.4.4. Recent Developments
  • 3.5. F. Hoffmann La-Roche AG
    • 3.5.1. Overview
    • 3.5.2. Financial Analysis
    • 3.5.3. SWOT Analysis
    • 3.5.4. Recent Developments
  • 3.6. Thermo Fisher Scientific, Inc.
    • 3.6.1. Overview
    • 3.6.2. Financial Analysis
    • 3.6.3. SWOT Analysis
  • 3.7. Key Strategy Analysis

4. Market Segmentation

  • 4.1. Global Molecular Cytogenetics Market by Product
    • 4.1.1. Consumables
    • 4.1.2. Software & Services
    • 4.1.3. Instruments
  • 4.2. Global Molecular Cytogenetics Market by Application
    • 4.2.1. Cancer
    • 4.2.2. Genetic Disorders
    • 4.2.3. Personalized Medicine
  • 4.3. Global Molecular Cytogenetics Market by Technique
    • 4.3.1. Fluorescence in Situ Hybridization (FISH)
    • 4.3.2. Comparative Genomic Hybridization (CGH)
    • 4.3.3. Others

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. United States
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. South Korea
    • 5.3.5. Rest of Asia-Pacific
  • 5.4. Rest of the World

6. Company Profiles

  • 6.1. Abbott Laboratories, Inc.
  • 6.2. ADS Biotec Inc.
  • 6.3. Agilent Technologies, Inc.
  • 6.4. Applied Spectral Imaging
  • 6.5. BioDot Inc.
  • 6.6. Biological Industries Israel Beit Haemek Ltd.
  • 6.7. Bio-Rad Laboratories, Inc.
  • 6.8. Danaher Corp.
  • 6.9. Euroclone S.p.A.
  • 6.10. F. Hoffmann La-Roche AG
  • 6.11. FUJIFILM Irvine Scientific
  • 6.12. Illumina, Inc.
  • 6.13. Laboratory Imaging s.r.o.
  • 6.14. Leica Biosystems
  • 6.15. MetaSystems Hard & Software GmbH
  • 6.16. Nikon Corp.
  • 6.17. Oxford Gene Technology Ltd.
  • 6.18. PAN-Biotech GmbH
  • 6.19. Perkinelmer, Inc.
  • 6.20. Tecan Group Ltd.
  • 6.21. Thermo Fisher Scientific Inc.